Healthcare Dealmaking Symposium

When: March 10, 2009
Where: The Union League Club - New York, NY

Join leaders in healthcare industries and the engineers of successful transactions in this space at The Deal's third annual Healthcare Dealmaking Symposium in March. This one day program gathers the healthcare dealmaking community to discuss an outlook on mergers and acquisitions, pressing healthcare regulatory issues and the key trends and opportunities anticipated across pharmaceuticals, biotech, drug discovery, medical devices, healthcare services and technology sectors in the next 12 months.

Who Should Attend?
The Healthcare Dealmaking Symposium is a must for all dealmakers in the healthcare sector including:

• Corporate development executives
• Hedge Fund managers
• Private Equity groups
• Venture Investors
• Investment Bankers
• Intermediary professionals
• Professional Service providers

For more information about sponsorship and exhibitor opportunities,
please contact:
Allan Cunningham
Vice President, Marketing
212.313.9162
acunningham@TheDeal.com

More video coverage

• Jonathan Korngold, Managing Director, General Atlantic LLC:

• Jonathan Korngold, Managing Director, General Atlantic, LLC:

Complete archive from The Deal Video

Editorial coverage from the 2009 conference

PE dealmakers: Healthcare opportunities exist

Despite uncertainty around the administration's healthcare reform plans, dealmakers at The Deal LLC's Healthcare Dealmaking Symposium see opportunities in pharmaceutical and biotech deals.

More antitrust scrutiny for pharmas

At The Deal LLC's Healthcare Dealmaking Symposium, a Tuesday morning panel discussed the possibility of growing antitrust scrutiny by the Obama administration for healthcare deals.

Mintz Levin's Berson on healthcare reform

Speaking at The Deal LLC's Healthcare Dealmaking Symposium, the Mintz Levin attorney said Congress needs some education on existing programs before reforming the system.

Will Obama's healthcare reform work?

At The Deal LLC's Healthcare Dealmaking Symposium, a Tuesday morning panel discussed the necessary changes President Obama must undertake to successfully reform healthcare in the U.S.

Psilos Group's Waxman on controlling healthcare costs

Dr. Albert Waxman, the CEO of venture capital firm Psilos Group, spoke at The Deal's Healthcare Dealmaking Symposium about ways to control healthcare costs.

OrbiMed's Sam Isaly on healthcare M&A

Sam Isaly, the founder and managing partner at private equity firm OrbiMed Advisor, was the subject of the Tuesday morning keynote interview at The Deal LLC's Healthcare Dealmaking Symposium.

Sullivan & Cromwell's Pagnani on biotech M&A

At The Deal LLC's Healthcare Dealmaking Symposium, attorney Keith Pagnani commented on how the dealmaking landscape for biotechs is changing.

PE pros on healthcare dealmaking

At The Deal LLC's Healthcare Dealmaking Symposium Tuesday morning, a group of private equity professionals spoke about the M&A landscape in the sector.

Dealmaker sees healthcare M&A slowdown

Richard H. Stowe, general partner at Health Enterprise Partners, said the recession is taking its toll on healthcare and pharma mergers despite a few recent megadeals.

Complete archive from Dealscape